06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.74
+9.70%Margins
Gross margin
64.7%
EBITDA margin
-353.7%
EBIT margin
-524.6%
Net margin
-569.5%
FCF margin
-256.5%
-29.2%
Return on equity
-18.1%
Return on assets
-21.5%
Return on invested capital
0.03x
Asset turnover
-HKD 81.8M
Cash from operations
HKD 0.01
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026